ML增强了对 ангиотензинII受体的生物活性预测:一种潜在的抗高血压药物标
Jeyanthi Sankar1, Venkatesh Rajendran1, Beena Briget Kuriakose2
1Pharmacogenomics and CADD Lab, Department of Bioinformatics, Alagappa University, Karaikudi, 630 003, Tamil Nadu, India.
Scientific reports
|July 14, 2025
概括
人工智能 (AI) 通过使用定量结构-活性关系 (QSAR) 模型预测对 ангиотензинII受体的生物活性来加速药物发现. 这种方法增强了领先的识别,并降低了开发成本.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算化学计算化学
- 生物信息学是一种生物信息学.
背景情况:
- 药物发现是一个复杂的,多阶段的过程,需要广泛的研究,开发和测试.
- 人工智能 (AI) 为分析大型数据集提供了强大的能力,以识别药物发现中的复杂模式.
- ангиотензинII受体是管理高血压和相关心血管和脏疾病的关键标.
研究的目的:
- 引入一个人工智能驱动的生物活性预测应用程序.
- 使用定量结构-活性关系 (QSAR) 模型来预测候选药物活性.
- 针对潜在的治疗干预的 ангиотензинII受体.
主要方法:
- 开发一种生物活性预测应用程序.
- 实施定量结构-活动关系 (QSAR) 建模.
- 大数据集的AI驱动分析用于模式识别.
主要成果:
- 人工智能应用成功地预测了对抗 ангиотензинII受体的生物活性.
- 确定了对高血压和相关疾病有前途的候选药物.
- 证明了加快领先优化和降低研发成本的潜力.
结论:
- 人工智能和QSAR建模显著提高了药物发现的效率.
- 这种方法加快了对心血管和脏疾病的潜在治疗方法的识别.
- 减少了广泛的体外和体内测试的必要性,优化了资源配置.
相关概念视频
Antihypertensive Drugs: Angiotensin II Receptor Blockers
930
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
930
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
892
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
892
Antihypertensive Drugs: Direct Renin Inhibitors
833
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
833
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
513
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
513
Antihypertensive Drugs: Action of β1 Blockers
614
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
614
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K


